MedPath

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

Phase 1
Completed
Conditions
Diabetes
Gastric Bypass
Interventions
Procedure: Mixed Meal Tolerance test, Hyperglycemic clamp
Registration Number
NCT00488423
Lead Sponsor
The Cleveland Clinic
Brief Summary

MIDAS involves an assessment of glucose levels obtained before and after bariatric surgery. There are two different procedural tests involved; an oral glucose tolerance test (mixed meal) and a hyperglycemic clamp test. Two tests are performed preoperatively and five more are performed postoperatively for a one year period. The associated labwork drawn with the mixed meal and clamp tests are demonstrating changes in glucose, insulin and gut hormone levels.

Detailed Description

Tests performed are the Mixed Meal tolerance test, the Hyperglycemic Clamp test, c-peptide, free fatty acids, adipocyte hormone profile levels.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Negative pregnancy test if female
  • ADA criteria for diabetes type II
  • Hematocrit > 35 creatinine < 1.9, AST < 3X upper limit of normal, ALT < 3X upper limit of normal, alkaline phos <3X upper limit of normal
  • Eligibility for bariatric surgery based on the NIH and clinical criteria
  • Mentally and legally capable of providing consent
Exclusion Criteria
  • Lactating females
  • Must not have type I diabetes
  • Systemic steroids taken within 6 months
  • Clinically significant heart disease
  • Recent pulmonary embolism, untreated proliferative retinopathy, renal failure, uncontrolled hypertension, autonomic neuropathy, resting heart rate > 100, neuromuscular or musculoskeletal disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lap-bandMixed Meal Tolerance test, Hyperglycemic clampPatient undergoing Lap-band Bariatric Surgery
Gastric BypassMixed Meal Tolerance test, Hyperglycemic clampPatient's undergoing Laparoscopic Roux-N Y Gastric Bypass surgery.
Primary Outcome Measures
NameTimeMethod
To assess the effect of gastric by-pass surgery to decrease lipotoxicity.One year
Secondary Outcome Measures
NameTimeMethod
To examine the effect of roux-en-Y compared to gastric banding on pancreatic B cell recovery or insulin secretion in response to oral and IV glucose.One Year

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath